Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/18/19
End: 03/20/20
Due: 03/20/21
Phase: N/A
Priority: Normal
Start: 10/28/20
End: 09/07/22
Due: 09/07/23
Phase: N/A
Priority: Normal
Start: 04/25/22
End: 06/24/22
Due: 06/24/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| First in Human Clinical Trial of ApTOLL in Healthy Volunteers | NCT04742062 | aptaTargets S.L. | user2@example.com | None | 2019-07-18 | 2020-03-20 | 2021-03-20 | - | - | 2025-07-14 |
| Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke | NCT04734548 | aptaTargets S.L. | user2@example.com | None | 2020-10-28 | 2022-09-07 | 2023-09-07 | - | - | 2025-07-14 |
| First in Human Study to Compare Safety Between Intravenous Bolus Versus Infusion of ApTOLL | NCT05569720 | aptaTargets S.L. | user2@example.com | None | 2022-04-25 | 2022-06-24 | 2023-06-24 | - | - | 2025-07-14 |